<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">In vitro Immunobiological Studies of Novel 5-(5-nitrofuran-2-yl)-1, 3, 4- Thiadiazoles with Piperazinyl-Linked Benzamidine Substituents against Leishmania Major</title>
    <FirstPage>368</FirstPage>
    <LastPage>376</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Farzaneh</FirstName>
        <LastName>Rezazadeh Marznaki</LastName>
        <affiliation locale="en_US">Institute of Biochemistry and Biophysics, Department of Biochemistry, University of Tehran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Raheleh</FirstName>
        <LastName>Shakeri</LastName>
        <affiliation locale="en_US">Institute of Biochemistry and Biophysics, Department of Biochemistry, University of Tehran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sussan</FirstName>
        <LastName>Kaboudanian Ardestani</LastName>
        <affiliation locale="en_US">Institute of Biochemistry and Biophysics, Department of Biochemistry, University of Tehran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Azar</FirstName>
        <LastName>Tahghighi</LastName>
        <affiliation locale="en_US">Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Foroumadi</LastName>
        <affiliation locale="en_US">Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">It&#xA0; was recently demonstrated that 5-(5-nitrofuran-2-yl)-1, 3, 4-thiadiazoles&#xA0; with piperazinyl-linked benzamidine substituents are effective in vitro against Leishmania major.
Following on this evidence, we used colorimetric assay of acid phosphatase activity in the promastigotes&#xA0; as&#xA0; an&#xA0; indicator&#xA0; for&#xA0; cell&#xA0; viability.&#xA0; Also&#xA0; we&#xA0; studied&#xA0; the&#xA0; effect&#xA0; of&#xA0; these compounds on induction of nitric oxide (NO) in macrophage and production of reactive oxygen species (ROS) in lymphocyte that have important role in activation of immune response against Leishmania and elimination of parasite.
Results showed that these compounds decrease the viability of the parasite and increase ROS and NO production in lymphocyte and macrophage respectively.
These compounds can induce parasite killing, directly by decreasing the parasite viability and indirectly by exhibiting a significant increase on immune system.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/490</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/490/554</pdf_url>
  </Article>
</Articles>
